CoChat
Cited by 123

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy

Birks, E. J., Latif, N., Enesa, K., Folkvang, T., Luong, L. A., Sarathchandra, P., Khan, M., Ovaa, H., Terracciano, C. M., Barton, P. J.R., Yacoub, M. H., Evans, P. C. · 2008 · Cardiovascular Research

Abstract

AIMS: The molecular mechanisms that regulate cardiomyocyte apoptosis and their role in human heart failure (HF) are uncertain. Expression of the apoptosis regulator p53 is governed by minute double minute 2 (MDM2), an E3 enzyme that targets p53 for ubiquitination and proteasomal processing, and by the deubiquitinating enzyme, herpesvirus-associated ubiquitin-specific protease (HAUSP), which rescues p53 by removing ubiquitin chains from it. Here, we examined whether elevated expression of p53 was associated with dysregulation of ubiquitin-proteasome system (UPS) components and activation of downstream effectors of apoptosis in human dilated cardiomyopathy (DCM). METHODS AND RESULTS: Left ventricular myocardial samples were obtained from patients with DCM (n = 12) or from non-failing (donor) hearts (n = 17). Western blotting and immunohistochemistry revealed that DCM tissues contained elevated levels of p53 and its regulators MDM2 and HAUSP (all P < 0.01) compared with non-failing hearts. DCM tissues also contained elevated levels of polyubiquitinated proteins and possessed enhanced 20S-proteasome chymotrypsin-like activities (P < 0.04) as measured in vitro using a fluorogenic substrate. DCM tissues contained activated caspases-9 and -3 (P < 0.001) and reduced expression of the caspase substrate PARP-1 (P < 0.05). Western blotting and immunohistochemistry revealed that DCM tissues contained elevated expression levels of caspase-3-activated DNAse (CAD; P < 0.001), which is a key effector of DNA fragmentation in apoptosis and also contained elevated expression of a potent inhibitor of CAD (ICAD-S; P < 0.01). CONCLUSION: Expression of p53 in human DCM is associated with dysregulation of UPS components, which are known to regulate p53 stability. Elevated p53 expression and caspase activation in DCM was not associated with activation of both CAD and its inhibitor, ICAD-S. Our findings are consistent with the concept that apoptosis may be interrupted and therefore potentially reversible in human HF.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cvr/cvn083

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 36

  1. Song, 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 18, 744, 10.1016/S1053-2498(98)00039-4 · DOI
  2. 1997, The FASEB Journal, 11, 2867
  3. Regula, 2001, Journal of molecular and cellular cardiology, 33, 1435, 10.1006/jmcc.2001.1405 · DOI
  4. Ikeda, 1999, Life sciences, 65, 925, 10.1016/S0024-3205(99)00322-7 · DOI
  5. 2007, 446, 444, 10.1038/nature05602 · DOI · Paper page
  6. Tsukamoto, 2006, Biochemical and biophysical research communications, 340, 1125, 10.1016/j.bbrc.2005.12.120 · DOI
  7. 1998, 97, 194, 10.1161/01.CIR.97.2.194 · DOI
  8. Narula, 1999, PNAS, 96, 8144, 10.1073/pnas.96.14.8144 · DOI · Paper page
  9. van Empel, 2005, Cardiovascular Research, 67, 21, 10.1016/j.cardiores.2005.04.012 · DOI · Paper page
  10. 1998, 391, 96, 10.1038/34214 · DOI · Paper page
  11. Widlak, 2005, Journal of cellular biochemistry, 94, 1078, 10.1002/jcb.20409 · DOI · Paper page
  12. 2007, Circulation Research, 100, 645, 10.1161/01.RES.0000260203.55077.61 · DOI
  13. Wencker, 2003, Journal of Clinical Investigation, 111, 1497, 10.1172/JCI200317664 · DOI
  14. Els sser, 2000, Journal of molecular and cellular cardiology, 32, 711, 10.1006/jmcc.2000.1125 · DOI · Paper page
  15. Kang, 2000, Circulation Research, 86, 1107, 10.1161/01.RES.86.11.1107 · DOI · Paper page
  16. Takemura, 2006, Journal of cellular and molecular medicine, 10, 56, 10.1111/j.1582-4934.2006.tb00291.x · DOI
  17. Haider, 2002, Journal of cardiac failure, 8, S512, 10.1054/jcaf.2002.130034 · DOI
  18. 2006, 3, 681, 10.1038/ncpcardio0710 · DOI
  19. Latif, 2000, Journal of the American College of Cardiology, 35, 1769, 10.1016/S0735-1097(00)00647-1 · DOI
  20. 2003, J PATH, 199, 229, 10.1002/path.1261 · DOI
  21. 1999, 99, 2757, 10.1161/01.CIR.99.21.2757 · DOI · Paper page
  22. Glickman, 2002, Physiological Reviews, 82, 373, 10.1152/physrev.00027.2001 · DOI · Paper page
  23. Fang, 2000, Journal of Biological Chemistry, 275, 8945, 10.1074/jbc.275.12.8945 · DOI · Paper page
  24. Yang, 2004, Oncogene, 23, 2096, 10.1038/sj.onc.1207411 · DOI · Paper page
  25. 2006, Journal of Biological Chemistry, 281, 3679, 10.1074/jbc.M509630200 · DOI
  26. 2002, 416, 648, 10.1038/nature737 · DOI · Paper page
  27. Powell, 2007, Journal of molecular and cellular cardiology, 42, 265, 10.1016/j.yjmcc.2006.10.010 · DOI
  28. Balasubramanian, 2006, Journal of molecular and cellular cardiology, 41, 669, 10.1016/j.yjmcc.2006.04.022 · DOI
  29. 2007, Journal of Biological Chemistry, 282, 5529, 10.1074/jbc.M609046200 · DOI
  30. Hamada, 2004, Molecular and Cellular Biology, 24, 8007, 10.1128/MCB.24.18.8007-8017.2004 · DOI · Paper page
  31. 2005, Circulation Research, 97, 1018, 10.1161/01.RES.0000189262.92896.0b · DOI · Paper page
  32. Li, 2005, The FASEB Journal, 19, 362, 10.1096/fj.04-2364com · DOI · Paper page
  33. Li, 2004, Journal of Clinical Investigation, 114, 1058, 10.1172/JCI200422220 · DOI · Paper page
  34. Eble, 1999, Cell and tissue research, 296, 541, 10.1007/s004410051315 · DOI
  35. Sakahira, 1999, Journal of Biological Chemistry, 274, 15740, 10.1074/jbc.274.22.15740 · DOI
  36. Gu, 1999, Journal of Biological Chemistry, 274, 20759, 10.1074/jbc.274.30.20759 · doi:10.1074/jbc.274.30.20759

Cited by

See all 123

Metadata

Authors
Birks, E. J., Latif, N., Enesa, K., Folkvang, T., Luong, L. A., Sarathchandra, P., Khan, M., Ovaa, H., Terracciano, C. M., Barton, P. J. R., Yacoub, M. H., & Evans, P. C.
Venue
Cardiovascular Research
Published
2008-05-02
Volume
79
Issue
3
Pages
472-480
ISSN
0008-6363
Cited by
123
References
4
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.